As of 2025-09-15, the Relative Valuation of Cara Therapeutics Inc (CARA) is (290.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -5565.3%.
The range of the Relative Valuation is (280.99) - (293.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 18.9x | 18.8x |
| Forward P/E multiples | 18.1x - 19.7x | 18.8x |
| Fair Price | (280.99) - (293.08) | (290.76) |
| Upside | -5381.7% - -5609.1% | -5565.3% |
| Date | P/E |